Serum- and glucocorticoid-inducible kinase 1 in doxorubicin-induced nephrotic syndrome

American Journal of Physiology - Renal Physiology

Volumn 295, Issue 6, 2008, Pages

  Artunc, Ferruh ^a,c   Nasir, Omaima ^a   Amann, Kerstin ^b   Boini, Krishna M ^a   Häring, Hans Ulrich ^a   Risler, Teut ^a   Lang, Florian ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Ascites; Mice; Proteinuria; Sodium

Indexed keywords

ALDOSTERONE; DOXORUBICIN; SERUM AND GLUCOCORTICOID REGULATED KINASE 1; SODIUM; UREA;

ALDOSTERONE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASCITES; CONTROLLED STUDY; DRUG INDUCED DISEASE; FLUID RETENTION; GENOTYPE; HYPERLIPIDEMIA; HYPOALBUMINEMIA; KIDNEY FIBROSIS; KNOCKOUT MOUSE; MOUSE; NEPHROTIC SYNDROME; NONHUMAN; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEINURIA; SODIUM URINE LEVEL; UREA BLOOD LEVEL; UREMIA; WILD TYPE;

EID: 57349136748     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00032.2008     Document Type: Article

References (55)

1. Amato R, Menniti M, Agosti V, Boito R, Costa N, Bond HM, Barbieri V, Tagliaferri P, Venuta S, Perrotti N. IL-2 signals through Sgk1 and inhibits proliferation and apoptosis in kidney cancer cells. J Mol Med 85: 707-721, 2007.
2. Aoyama T, Matsui T, Novikov M, Park J, Hemmings B, Rosenzweig A. Serum and glucocorticoid-responsive kinase-1 regulates cardiomyocyte survival and hypertrophic response. Circulation 111: 1652-1659, 2005.
3. Artunc F, Amann K, Nasir O, Friedrich B, Sandulache D, Jahovic N, Risler T, Vallon V, Wulff P, Kuhl D, Lang F. Blunted DOCA/high salt induced albuminuria and renal tubulointerstitial damage in gene-targeted mice lacking SGK1. J Mol Med 84: 737-746, 2006.
4. Artunc F, Sandulache D, Nasir O, Boini KM, Friedrich B, Beier N, Dicks E, Poetsch S, Klingel K, Amann K, Blazer-Yost B, Scholz W, Risler T, Kuhl D, Lang F. Lack of the serum and glucocorticoid inducible kinase SGK1 attenuates the volume retention following treatment with the PPARgamma agonist pioglitazone. Pflügers Arch 456: 425-436, 2008.
5. Audige A, Yu ZR, Frey BM, Uehlinger DE, Frey FJ, Vogt B. Epithelial sodium channel (ENaC) subunit mRNA and protein expression in rats with puromycin aminonucleoside-induced nephrotic syndrome. Clin Sci (Lond) 104: 389-395, 2003.
6. Bertani T, Poggi A, Pozzoni R, Delaini F, Sacchi G, Thoua Y, Mecca G, Remuzzi G, Donati MB. Adriamycin-induced nephrotic syndrome in rats: sequence of pathologic events. Lab Invest 46: 16-23, 1982.
7. Bhargava A, Fullerton MJ, Myles K, Purdy TM, Funder JW, Pearce D, Cole TJ. The serum- and glucocorticoid-induced kinase is a physiological mediator of aldosterone action. Endocrinology 142: 1587-1594, 2001.
8. Bistrup C, Thiesson HC, Jensen BL, Skott O. Reduced activity of 11beta-hydroxysteroid dehydrogenase type 2 is not responsible for sodium retention in nephrotic rats. Acta Physiol Scand 184: 161-169, 2005.
9. Brennan FE, Fuller PJ. Rapid upregulation of serum and glucocorticoid-regulated kinase (sgk) gene expression by corticosteroids in vivo. Mol Cell Endocrinol 166: 129-136, 2000.
10. Chen A, Sheu LF, Ho YS, Lin YF, Chou WY, Chou TC, Lee WH. Experimental focal segmental glomerulosclerosis in mice. Nephron 78: 440-452, 1998.
11. Chen A, Wei CH, Sheu LF, Ding SL, Lee WH. Induction of proteinuria by adriamycin or bovine serum albumin in the mouse. Nephron 69: 293-300, 1995.
12. Chen SY, Bhargava A, Mastroberardino L, Meijer OC, Wang J, Buse P, Firestone GL, Verrey F, Pearce D. Epithelial sodium channel regulated by aldosterone-induced protein sgk. Proc Natl Acad Sci USA 96: 2514-2519, 1999.
13. De Seigneux S, Kim SW, Hemmingsen SC, Frokiaer J, Nielsen S. Increased expression but not targeting of ENaC in adrenalectomized rats with PAN-induced nephrotic syndrome. Am J Physiol Renal Physiol 291: F208-F217, 2006.
14. +)-ATPase activity is correlated with urinary sodium excretion in rat nephrotic syndromes. J Am Soc Nephrol 11: 604-615, 2000.
15. Deschenes G, Wittner M, Stefano A, Jounier S, Doucet A. Collecting duct is a site of sodium retention in PAN nephrosis: a rationale for amiloride therapy. J Am Soc Nephrol 12: 598-601, 2001.
16. Driver PM, Rauz S, Walker EA, Hewison M, Kilby MD, Stewart PM. Characterization of human trophoblast as a mineralocorticoid target tissue. Mol Hum Reprod 9: 793-798, 2003.
17. Erkan E, Garcia CD, Patterson LT, Mishra J, Mitsnefes MM, Kaskel FJ, Devarajan P. Induction of renal tubular cell apoptosis in focal segmental glomerulosclerosis: roles of proteinuria and Fas-dependent pathways. J Am Soc Nephrol 16: 398-407, 2005.
18. Feehally J, Floege J, Johnson R. Comprehensive Clinical Nephrology. Philadelphia, PA: Mosby, 2007.
19. Fillon S, Klingel K, Warntges S, Sauter M, Gabrysch S, Pestel S, Tanneur V, Waldegger S, Zipfel A, Viebahn R, Haussinger D, Broer S, Kandolf R, Lang F. Expression of the serine/threonine kinase hSGK1 in chronic viral hepatitis. Cell Physiol Biochem 12: 47-54, 2002.
20. Firestone GL, Giampaolo JR, O'Keeffe BA. Stimulus-dependent regulation of serum and glucocorticoid inducible protein kinase (SGK) transcription, subcellular localization and enzymatic activity. Cell Physiol Biochem 13: 1-12, 2003.
21. Foldager N, Blomqvist CG. Repeated plasma volume determination with the Evans Blue dye dilution technique: the method and a computer program. Comput Biol Med 21: 35-41, 1991.
22. Friedrich B, Warntges S, Klingel K, Sauter M, Kandolf R, Risler T, Muller GA, Witzgall R, Kriz W, Grone HJ, Lang F. Upregulation of the human serum and glucocorticoid-dependent kinase 1 in glomerulonephritis. Kidney Blood Press Res 25: 303-307, 2002.
23. Gumz ML, Popp MP, Wingo CS, Cain BD. Early transcriptional effects of aldosterone in a mouse inner medullary collecting duct cell line. Am J Physiol Renal Physiol 285: F664-F673, 2003.
24. Huber SM, Friedrich B, Klingel K, Lenka N, Hescheler J, Lang F. Protein and mRNA expression of serum and glucocorticoid-dependent kinase 1 in metanephrogenesis. Dev Dyn 221: 464-469, 2001.
25. Ichikawa I, Rennke HG, Hoyer JR, Badr KF, Schor N, Troy JL, Lechene CP, Brenner BM. Role for intrarenal mechanisms in the impaired salt excretion of experimental nephrotic syndrome. J Clin Invest 71: 91-103, 1983.
26. Kanter PM, Bullard GA, Pilkiewicz FG, Mayer LD, Cullis PR, Pavelic ZP. Preclinical toxicology study of liposome encapsulated doxorubicin (TLC D-99): comparison with doxorubicin and empty liposomes in mice and dogs. In Vivo 7: 85-95, 1993.
27. Kellner M, Peiter A, Hafner M, Feuring M, Christ M, Wehling M, Falkenstein E, Losel R. Early aldosterone upregulated genes: new pathways for renal disease? Kidney Int 64: 1199-1207, 2003.
28. Kim SW, Wang W, Nielsen J, Praetorius J, Kwon TH, Knepper MA, Frokiaer J, Nielsen S. Increased expression and apical targeting of renal ENaC subunits in puromycin aminonucleoside-induced nephrotic syndrome in rats. Am J Physiol Renal Physiol 286: F922-F935, 2004.
29. Kimura M, Takahasi H, Ohtake T, Sato T, Hishida A, Nishimura M, Honda N. Interstrain differences in murine daunomycin-induced nephrosis. Nephron 63: 193-198, 1993.
30. Klingel K, Warntges S, Bock J, Wagner CA, Sauter M, Waldegger S, Kandolf R, Lang F. Expression of cell volume-regulated kinase h-sgk in pancreatic tissue. Am J Physiol Gastrointest Liver Physiol 279: G998-G1002, 2000.
31. Lang F, Bohmer C, Palmada M, Seebohm G, Strutz-Seebohm N, Vallon V. (Patho)physiological significance of the serum- and glucocorticoid- inducible kinase isoforms. Physiol Rev 86: 1151-1178, 2006.
32. Lang F, Klingel K, Wagner CA, Stegen C, Warntges S, Friedrich B, Lanzendorfer M, Melzig J, Moschen I, Steuer S, Waldegger S, Sauter M, Paulmichl M, Gerke V, Risler T, Gamba G, Capasso G, Kandolf R, Hebert SC, Massry SG, Broer S. Deranged transcriptional regulation of cell-volume-sensitive kinase hSGK in diabetic nephropathy. Proc Natl Acad Sci USA 97: 8157-8162, 2000.
33. Le Menuet D, Isnard R, Bichara M, Viengchareun S, Muffat-Joly M, Walker F, Zennaro MC, Lombes M. Alteration of cardiac and renal functions in transgenic mice overexpressing human mineralocorticoid receptor. J Biol Chem 276: 38911-38920, 2001.
34. Loffing J, Zecevic M, Feraille E, Kaissling B, Asher C, Rossier BC, Firestone GL, Pearce D, Verrey F. Aldosterone induces rapid apical translocation of ENaC in early portion of renal collecting system: possible role of SGK. Am J Physiol Renal Physiol 280: F675-F682, 2001.
35. Lourdel S, Loffing J, Favre G, Paulais M, Nissant A, Fakitsas P, Creminon C, Feraille E, Verrey F, Teulon J, Doucet A, Deschenes G. Hyperaldosteronemia and activation of the epithelial sodium channel are not required for sodium retention in puromycin-induced nephrosis. J Am Soc Nephrol 16: 3642-3650, 2005.
36. + channels. J Biol Chem 274: 16973-16978, 1999.
37. Nasir O, Artunc F, Saeed A, Kambal MA, Kalbacher H, Sandulache D, Boini KM, Jahovic N, Lang F. Effects of gum arabic (Acacia senegal) on water and electrolyte balance in healthy mice. Journal of Renal Nutrition In press.
38. Okuda S, Oh Y, Tsuruda H, Onoyama K, Fujimi S, Fujishima M. Adriamycin-induced nephropathy as a model of chronic progressive glomerular disease. Kidney Int 29: 502-510, 1986.
39. Orth SR, Ritz E. The nephrotic syndrome. N Engl J Med 338: 1202-1211, 1998.
40. Ryan GB, Karnovsky MJ. An ultrastructural study of the mechanisms of proteinuria in aminonucleoside nephrosis. Kidney Int 8: 219-232, 1975.
41. + ATPase by the serum and glucocorticoid-dependent kinase sgk1. Pflügers Arch 444: 426-431, 2002.
42. + channel. Am J Physiol Renal Physiol 278: F613-F619, 2000.
43. L-Asparaginase, colchicine, lysine acetylsalicylate, and pyridinol carbamate. Can J Physiol Pharmacol 53: 368-374, 1975.
44. Vallon V, Wyatt AW, Klingel K, Huang DY, Hussain A, Berchtold S, Friedrich B, Grahammer F, Belaiba RS, Gorlach A, Wulff P, Daut J, Dalton ND, Ross J Jr, Flogel U, Schrader J, Osswald H, Kandolf R, Kuhl D, Lang F. SGK1-dependent cardiac CTGF formation and fibrosis following DOCA treatment. J Mol Med 84: 396-404, 2006.
45. Verrey F, Summa V, Heitzmann D, Mordasini D, Vandewalle A, Feraille E, Zecevic M. Short-term aldosterone action on Na,K-ATPase surface expression: role of aldosterone-induced SGK1? Ann NY Acad Sci 986: 554-561, 2003.
46. Vielhauer V, Berning E, Eis V, Kretzler M, Segerer S, Strutz F, Horuk R, Grone HJ, Schlondorff D, Anders HJ. CCR1 blockade reduces interstitial inflammation and fibrosis in mice with glomerulosclerosis and nephrotic syndrome. Kidney Int 66: 2264-2278, 2004.
47. Waldegger S, Barth P, Raber G, Lang F. Cloning and characterization of a putative human serine/threonine protein kinase transcriptionally modified during anisotonic and isotonic alterations of cell volume. Proc Natl Acad Sci USA 94: 4440-4445, 1997.
48. Waldegger S, Klingel K, Barth P, Sauter M, Rfer ML, Kandolf R, Lang F. h-sgk serine-threonine protein kinase gene as transcriptional target of transforming growth factor beta in human intestine. Gastroenterology 116: 1081-1088, 1999.
49. Wang Y, Wang YP, Tay YC, Harris DC. Progressive adriamycin nephropathy in mice: sequence of histologic and immunohistochemical events. Kidney Int 58: 1797-1804, 2000.
50. Wärntges S, Klingel K, Weigert C, Fillon S, Buck M, Schleicher E, Rodemann HP, Knabbe C, Kandolf R, Lang F. Excessive transcription of the human serum and glucocorticoid dependent kinase hSGK1 in lung fibrosis. Cell Physiol Biochem 12: 135-142, 2002.
51. + retention in the sgk1-knockout mouse. J Clin Invest 110: 1263-1268, 2002.
52. Yu Z, Schumacher M, Frey BM, Frey FJ, Vogt B. Regulation of epithelial sodium channel in puromycin aminonucleoside-induced unilateral experimental nephrotic syndrome in normal and analbuminemic Nagase rats. Nephron Physiol 101: 51-62, 2005.
53. + channel ROMK1. J Am Soc Nephrol 13: 2823-2830, 2002.
54. Zecevic M, Heitzmann D, Camargo SM, Verrey F. SGK1 increases Na,K-ATP cell-surface expression and function in Xenopus laevis oocytes. Pflügers Arch 448: 29-35, 2004.
55. Zheng Z, Schmidt-Ott KM, Chua S, Foster KA, Frankel RZ, Pavlidis P, Barasch J, D'Agati VD, Gharavi AG. A Mendelian locus on chromosome 16 determines susceptibility to doxorubicin nephropathy in the mouse. Proc Natl Acad Sci USA 102: 2502-2507, 2005.